16 Views

CRT 2026

Endovascular

Session:: Hot Topics in Endovascular Interventions | Sunday | Sponsored by Cook Medical [Non-CME]

Live Case Broadcasting From Main Line Health Lankenau Heart Institute | Wynnewood, Pennsylvania

Sunday, March 8, 2026

11:14 AM - 11:45 AM EST

Location: Jefferson

Live Case Operator(s)

William A. Gray, MD, FSCAI

System Chief of Cardiovascular Services, Main Line Health/President, Lankenau Heart Institute
Main Line Health
Wynnewood, Pennsylvania, United States

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)
William A. Gray, MD, FSCAI

System Chief of Cardiovascular Services, Main Line Health/President, Lankenau Heart Institute
Main Line Health
Wynnewood, Pennsylvania, United States

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)

Moderator(s)

Leonardo C. Clavijo, MD, PhD, FACC, FSCAI

Interventional Cardiologist
Adventist Hospital St. Helena
Saint Helena, California, United States

Disclosure(s): No financial relationships to disclose
Leonardo C. Clavijo, MD, PhD, FACC, FSCAI

Interventional Cardiologist
Adventist Hospital St. Helena
Saint Helena, California, United States

Disclosure(s): No financial relationships to disclose
Khusrow A. Niazi, MD, FACC, FSCAI, FSVM

Director Peripheral Vascular Interventions
Emory University
Dunwoody, Georgia, United States

Disclosure(s): Cordis, Endovascular Division: Grant/Research Support (Ongoing)
Khusrow A. Niazi, MD, FACC, FSCAI, FSVM

Director Peripheral Vascular Interventions
Emory University
Dunwoody, Georgia, United States

Disclosure(s): Cordis, Endovascular Division: Grant/Research Support (Ongoing)
Gunnar Tepe, MD

Head of Department of Diagnostic and Interventional Radiology
Hospital of Rosenhein
Rosenheim, Germany

Disclosure information not submitted.
Gunnar Tepe, MD

Head of Department of Diagnostic and Interventional Radiology
Hospital of Rosenhein
Rosenheim, Germany

Disclosure information not submitted.

Panel Discussant(s)

Robert E. Beasley, MD, FSIR, FSCAI

Director of Research and Endovascular Specialist
Palm Vascular Centers of MB and Coral Gables
Miami, Florida, United States

Disclosure(s): No financial relationships to disclose
Robert E. Beasley, MD, FSIR, FSCAI

Director of Research and Endovascular Specialist
Palm Vascular Centers of MB and Coral Gables
Miami, Florida, United States

Disclosure(s): No financial relationships to disclose
Marianne Brodmann, MD

Head of Divsion of Angiology, Medical University Graz
Medical University Graz
Graz, Steiermark, Austria

Disclosure(s): No financial relationships to disclose
Marianne Brodmann, MD

Head of Divsion of Angiology, Medical University Graz
Medical University Graz
Graz, Steiermark, Austria

Disclosure(s): No financial relationships to disclose
Mehmet Cilingiroglu, MD

Professor
University of Hawaii John Burns School of Medicine
San Diego, California, United States

Disclosure(s): No financial relationships to disclose
Mehmet Cilingiroglu, MD

Professor
University of Hawaii John Burns School of Medicine
San Diego, California, United States

Disclosure(s): No financial relationships to disclose
JD Corl, FACC, FSCAI

Medical Director of PAD/CLI Program at The Christ Hospital
The Christ Hospital
Cincinnati, Ohio, United States

Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
JD Corl, FACC, FSCAI

Medical Director of PAD/CLI Program at The Christ Hospital
The Christ Hospital
Cincinnati, Ohio, United States

Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Eric J. Dippel, MD

Interventional Cardiologist
Vascular Institute of the Midwest, PC
Bettendorf, Iowa, United States

Disclosure information not submitted.
Eric J. Dippel, MD

Interventional Cardiologist
Vascular Institute of the Midwest, PC
Bettendorf, Iowa, United States

Disclosure information not submitted.
Jihad A. Mustapha, MD FACC FSCAI

Interventional Cardiologist
Lorven Heart & Vascular Institute
Ada , Michigan, United States

Disclosure(s): Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing); Cagent Vascular: Stock Options [in privately held companies] (Ongoing); Cardioflow: board member/chief medical officer, equity ownership (Ongoing), Stock-privately held company (Ongoing); Euphrates: Stock Options [in privately held companies] (Ongoing); Glift: Stock Options [in privately held companies] (Ongoing); Iatri: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Immertec: Stock Options [in privately held companies] (Ongoing); Levee Medical: Stock Options [in privately held companies] (Ongoing); Micromedical Solutions: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Reflow Medical: Grant/Research Support (Ongoing), scientific advisory board (Ongoing), Stock-privately held company (Ongoing); SoundBite Medical: Stock-privately held company (Ongoing); Transit Medical: Stock Options [in privately held companies] (Ongoing); Versono: Consulting Fees (e.g., advisory boards) (Ongoing)
Jihad A. Mustapha, MD FACC FSCAI

Interventional Cardiologist
Lorven Heart & Vascular Institute
Ada , Michigan, United States

Disclosure(s): Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing); Cagent Vascular: Stock Options [in privately held companies] (Ongoing); Cardioflow: board member/chief medical officer, equity ownership (Ongoing), Stock-privately held company (Ongoing); Euphrates: Stock Options [in privately held companies] (Ongoing); Glift: Stock Options [in privately held companies] (Ongoing); Iatri: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Immertec: Stock Options [in privately held companies] (Ongoing); Levee Medical: Stock Options [in privately held companies] (Ongoing); Micromedical Solutions: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Reflow Medical: Grant/Research Support (Ongoing), scientific advisory board (Ongoing), Stock-privately held company (Ongoing); SoundBite Medical: Stock-privately held company (Ongoing); Transit Medical: Stock Options [in privately held companies] (Ongoing); Versono: Consulting Fees (e.g., advisory boards) (Ongoing)
Nicolas W. Shammas, MD, MS

Founder, President and Research Director
Midwest Cardiovascular Research Foundation
Davenport, Iowa, United States

Disclosure(s): Abbott Labs: Grant/Research Support (Ongoing); AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bard Peripheral Vascular, Inc.: Grant/Research Support (Ongoing)
Nicolas W. Shammas, MD, MS

Founder, President and Research Director
Midwest Cardiovascular Research Foundation
Davenport, Iowa, United States

Disclosure(s): Abbott Labs: Grant/Research Support (Ongoing); AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bard Peripheral Vascular, Inc.: Grant/Research Support (Ongoing)

Disclosure(s):

William A. Gray, MD, FSCAI: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)

Leonardo C. Clavijo, MD, PhD, FACC, FSCAI: No financial relationships to disclose

Khusrow A. Niazi, MD, FACC, FSCAI, FSVM: Cordis, Endovascular Division: Grant/Research Support (Ongoing)

Robert E. Beasley, MD, FSIR, FSCAI: No financial relationships to disclose

Marianne Brodmann, MD: No financial relationships to disclose

Mehmet Cilingiroglu, MD: No financial relationships to disclose

JD Corl, FACC, FSCAI: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Jihad A. Mustapha, MD FACC FSCAI: Asahi Intecc, Japan: Consulting Fees (e.g., advisory boards) (Ongoing); Cagent Vascular: Stock Options [in privately held companies] (Ongoing); Cardioflow: board member/chief medical officer, equity ownership (Ongoing), Stock-privately held company (Ongoing); Euphrates: Stock Options [in privately held companies] (Ongoing); Glift: Stock Options [in privately held companies] (Ongoing); Iatri: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Immertec: Stock Options [in privately held companies] (Ongoing); Levee Medical: Stock Options [in privately held companies] (Ongoing); Micromedical Solutions: board member/chief medical officer (Ongoing), Stock Options [in privately held companies] (Ongoing); Reflow Medical: Grant/Research Support (Ongoing), scientific advisory board (Ongoing), Stock-privately held company (Ongoing); SoundBite Medical: Stock-privately held company (Ongoing); Transit Medical: Stock Options [in privately held companies] (Ongoing); Versono: Consulting Fees (e.g., advisory boards) (Ongoing)

Nicolas W. Shammas, MD, MS: Abbott Labs: Grant/Research Support (Ongoing); AngioDynamics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bard Peripheral Vascular, Inc.: Grant/Research Support (Ongoing)